Single-Source Hypodermic Device Manufacturing

Raw Material to Sterile Finished Device— All Under One Roof

We machine the metal, mold the plastic, assemble in our Class 7 clean room, and deliver a sterile finished device — one facility, one quality system, one partner. Precision hypodermic-based devices for any application, manufactured in Avon, MA since 1888.

Precision Hypodermic Device CDMO

Metal + Plastics +STERILIZATION+ Sterile Packaging

11 precision processes, Class 7 & 8 cleanrooms, and an exclusive STERIS EO sterilization partnership. ISO 13485, MDSAP, EU MDR, and FDA registered. 40,000 sq. ft. of vertically integrated capability in Avon, MA.

Company SNAPSHOT

One Platform. Three Ways to Partner.

Ranfac’s vertically integrated manufacturing platform covers every step from raw metal and polymer to sterile finished device. Whether you need full development support, production-only scale, or access to our proprietary device portfolio, our 40,000 sq. ft. facility in Avon, MA delivers Class I and II hypodermic devices under one quality system, one roof.

Markets We Serve

Bone Access & Delivery

Orthobiologics

Spine

Minimally Invasive Surgery

Interventional Radiology

Hematology

Who We Are

Meet the Ranfac team and learn more about our mission to achieve excellence in medical device manufacturing.

Health Beacons Case Study

Case Study

Learn how Ranfac helped a leading virtual medical device development company overcome product design challenges to custom-manufacture and launch a transformative device that rapidly penetrated global markets.

Testimonials

What People Say

Regulatory-Ready for Global Markets

Ship to the US, EU, UK, Canada, Japan, Australia, and Brazil from a single qualified facility. Our quality system is audited under five regulatory frameworks simultaneously, so you never wait for additional certifications to enter a new market:

Start Your Project

Tell us about your hypodermic device — whether it needs development, production, or both — and we will show you how Ranfac’s single-source platform can get it to market faster.